FDA clears In-Line's access blood flow monitor:
This article was originally published in Clinica
In-Line Diagnostics has received US FDA 510(k) clearance to market its device for estimating access blood flow rate. The Transcutaneous Access Flow consists of a sensor that uses photo-optical technology to acquire a reading in a matter of minutes, compared to 15-20 minutes with current techniques, claims the Salt Lake City, Utah-based company. The device is for use with In-Line's Crit-Line blood monitoring system.